Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001401914-20-000073
Filing Date
2020-05-20
Accepted
2020-05-19 21:28:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 dare-lpcequitylinexsx1pros.htm 424B3 5566
2 darelpcequitylines1pr_image1.jpg GRAPHIC 130914
  Complete submission text file 0001401914-20-000073.txt   176442
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-237954 | Film No.: 20895533
SIC: 2834 Pharmaceutical Preparations